Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)-Reference-Cited by-同舟云学术

Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)

Published:2006-05 Issue:5 Volume:16 Page:334-336
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Arlet Jean-Benoit,Dimitri Dalia,Pagnoux Christian,Boyer Olivier,Maisonobe Thierry,Authier François-Jérome,Bloch-Queyrat Coralie,Goulvestre Claire,Heshmati Farhad,Atassi Marielle,Guillevin Loïc,Herson Serge,Benveniste Olivier,Mouthon Luc

Publisher

Elsevier BV

Subject

Genetics(clinical),Clinical Neurology,Neurology,Pediatrics, Perinatology, and Child Health

Reference10 articles.

1. Autoantibody profiles in the sera of European patients with myositis;Brouwer;Ann Rheum Dis,2001

2. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy;Kao;Arthritis Rheum,2004

3. Antibody to signal recognition particle in polymyositis;Targoff;Arthritis Rheum,1990

4. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups;Love;Medicine (Baltimore),1991

5. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis;Miller;N Engl J Med,1992

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-Mediated Necrotizing Myopathy Associated With Anti-signal Recognition Particle Antibody Complicated With Acute Respiratory Distress Syndrome: A Report of Two Cases;Cureus;2024-05-17

2. Plasma Exchange in Anti-Signal Recognition Particle Myopathy: A Systematic Review and Combined Analysis of Patient Individual Data;Journal of Personalized Medicine;2024-04-27

3. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies;Antibodies;2024-02-07

4. Pathogenesis and Treatment in IMNM;Current Treatment Options in Rheumatology;2023-03-22

5. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review;Biomedicine & Pharmacotherapy;2022-12